相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antigen-Specific IL-2 Secretion Correlates with NK Cell Responses after Immunization of Tanzanian Children with the RTS,S/AS01 Malaria Vaccine
Amir Horowitz et al.
JOURNAL OF IMMUNOLOGY (2012)
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2011)
Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children
Philip Bejon et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial
Kwaku Poku Asante et al.
LANCET INFECTIOUS DISEASES (2011)
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial
Ally Olotu et al.
LANCET INFECTIOUS DISEASES (2011)
Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
Daniel Dodoo et al.
MALARIA JOURNAL (2011)
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
Selidji Todagbe Agnandji et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibitory Effect of TNF-α on Malaria Pre-Erythrocytic Stage Development: Influence of Host Hepatocyte/Parasite Combinations
Nadya Depinay et al.
PLOS ONE (2011)
Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D
Selidji T. Agnandji et al.
PLOS ONE (2011)
T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children
Daniel Ansong et al.
PLOS ONE (2011)
Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells
Joanne M. Lumsden et al.
PLOS ONE (2011)
Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria
Ally Olotu et al.
PLOS ONE (2011)
Longevity and Composition of Cellular Immune Responses Following Experimental Plasmodium falciparum Malaria Infection in Humans
Anne C. Teirlinck et al.
PLOS PATHOGENS (2011)
Differential Effector Pathways Regulate Memory CD8 T Cell Immunity against Plasmodium berghei versus P. yoelii Sporozoites
Noah S. Butler et al.
JOURNAL OF IMMUNOLOGY (2010)
Randomized, Double-Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria-Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
Kent E. Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
Caterina Guinovart et al.
PLOS ONE (2009)
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Philip Bejon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Salim Abdulla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
GlaxoSmithKline Adjuvant systems in vaccines: concepts, achievements and perspectives
Nathalie Garcon et al.
EXPERT REVIEW OF VACCINES (2007)
The induction and persistence of T cell IFN-γ responses after vaccination or natural exposure is suppressed by Plasmodium falciparum
Philip Bejon et al.
JOURNAL OF IMMUNOLOGY (2007)
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique:: a Phase I/IIb randomized double-blind bridging trial
Eusebio V. Macete et al.
TRIALS (2007)
Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens
Gareth D. Weedall et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection
Sonia Enosse et al.
PLOS CLINICAL TRIALS (2006)
Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity
CL Hutchings et al.
JOURNAL OF IMMUNOLOGY (2005)
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites
P Bejon et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
WHH Reece et al.
NATURE MEDICINE (2004)
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children:: randomised controlled trial
PL Alonso et al.
LANCET (2004)
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
SJ McConkey et al.
NATURE MEDICINE (2003)
Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays
KL Flanagan et al.
JOURNAL OF IMMUNOLOGY (2001)
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria
KE Kester et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
分享论文
